T-Cell Solutions

T-Cell Solutions is a specialized business unit of Oxford Immunotec (now part of Revvity) that focuses on the development and commercialization of T-cell based diagnostic assays and research tools. The company is best known for its proprietary T-SPOT technology, which utilizes enzyme-linked immunospot (ELISPOT) methodology to measure antigen-specific T-cell responses with high sensitivity. Their primary commercial product, the T-SPOT.TB test, is a leading global diagnostic for latent tuberculosis infection. Beyond TB, T-Cell Solutions provides specialized kits and contract research services for monitoring immune responses in areas such as COVID-19, transplantation, and the development of novel T-cell therapies.